Search

Your search keyword '"Du QS"' showing total 80 results

Search Constraints

Start Over You searched for: Author "Du QS" Remove constraint Author: "Du QS"
80 results on '"Du QS"'

Search Results

1. Study on the lignin-derived sp 2 -sp 3 hybrid hard carbon materials and the feasibility for industrial production.

2. Study on the microcrystal cellulose and the derived 2D graphene and relative carbon materials.

3. Oral administration of dermatan sulphate reduces venous thrombus formation in vivo: potential use as a formulation for venous thromboembolism.

4. Enhanced production of optical ( S )-acetoin by a recombinant Escherichia coli whole-cell biocatalyst with NADH regeneration.

5. Fabrication and Characterization of Graphene Microcrystal Prepared from Lignin Refined from Sugarcane Bagasse.

6. A comparative study for the organic byproducts from hydrothermal carbonizations of sugarcane bagasse and its bio-refined components cellulose and lignin.

7. Simulated Protein Thermal Detection (SPTD) for Enzyme Thermostability Study and an Application Example for Pullulanase from Bacillus deramificans.

8. 2L-PCA: a two-level principal component analyzer for quantitative drug design and its applications.

9. Exploring the possibility to store the mixed oxygen-hydrogen cluster in clathrate hydrate in molar ratio 1:2 (O 2 +2H 2 ).

10. Active Hydrogen Bond Network (AHBN) and Applications for Improvement of Thermal Stability and pH-Sensitivity of Pullulanase from Bacillus naganoensis.

11. A new type of two-dimensional carbon crystal prepared from 1,3,5-trihydroxybenzene.

12. [Effects of hydrogen sulfide on mitochondria of lung in rats with ALI induced by lipopolysaccharide].

13. Microbial Routes to (2R,3R)-2,3-Butanediol: Recent Advances and Future Prospects.

14. Visualization analysis of CRISPR/Cas9 gene editing technology studies.

15. Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial.

16. Characterization and structural analysis of a potent anticoagulant phospholipase A2 from Pseudechis australis snake venom.

17. Exploring Strong Interactions in Proteins with Quantum Chemistry and Examples of Their Applications in Drug Design.

18. Insight into a molecular interaction force supporting peptide backbones and its implication to protein loops and folding.

19. Genome sequence of type strain Paenibacillus polymyxa DSM 365, a highly efficient producer of optically active (R,R)-2,3-butanediol.

20. Recent development of peptide drugs and advance on theory and methodology of peptide inhibitor design.

21. Genome Sequence of Tumebacillus flagellatus GST4, the First Genome Sequence of a Species in the Genus Tumebacillus.

22. In depth analysis on the binding sites of adamantane derivatives in HCV (hepatitis C virus) p7 channel based on the NMR structure.

23. Two-level QSAR network (2L-QSAR) for peptide inhibitor design based on amino acid properties and sequence positions.

24. Theoretical study on the polar hydrogen-π (Hp-π) interactions between protein side chains.

25. The multiple roles of histidine in protein interactions.

26. Unconventional interaction forces in protein and protein-ligand systems and their impacts to drug design.

27. Statistical energy potential: reduced representation of Dehouck-Gilis-Rooman function by selecting against decoy datasets.

28. Recent progress in computational approaches to studying the M2 proton channel and its implication to drug design against influenza viruses.

29. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.

30. Energies and physicochemical properties of cation-π interactions in biological structures.

31. [Effect of arctiin on mouse podocyte epithelial-mesenchymal transition induced by advanced oxidation protein products].

32. Differential regulation of myosin X movements by its cargos, DCC and neogenin.

33. Empirical formulation and parameterization of cation-π interactions for protein modeling.

34. Satellite RNA-derived small interfering RNA satsiR-12 targeting the 3' untranslated region of Cucumber mosaic virus triggers viral RNAs for degradation.

35. Organocatalytic asymmetric conjugate addition and cascade acyl transfer reaction of α-nitroketones.

36. Progress in structure-based drug design against influenza A virus.

37. [Connective tissue growth factor mediates high glucose-induced down-regulation of podocalyxin expression in mouse podocytes].

38. Structural position correlation analysis (SPCA) for protein family.

39. A possible CO2 conducting and concentrating mechanism in plant stomata SLAC1 channel.

40. Correlation analysis for protein evolutionary family based on amino acid position mutations and application in PDZ domain.

41. Advances in visual representation of molecular potentials.

42. RNA-dependent RNA polymerase 1 from Nicotiana tabacum suppresses RNA silencing and enhances viral infection in Nicotiana benthamiana.

43. Empirical and accurate method for the three-dimensional electrostatic potential (EM-ESP) of biomolecules.

44. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.

45. A fast and accurate method for predicting pKa of residues in proteins.

46. [Effects of small interfering RNA targeting connective tissue growth factor on high glucose-induced human tubular epithelial hypertrophy].

47. Regulation of heterochromatin remodelling and myogenin expression during muscle differentiation by FAK interaction with MBD2.

48. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.

49. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus.

50. Investigation into adamantane-based M2 inhibitors with FB-QSAR.

Catalog

Books, media, physical & digital resources